Hasil Pencarian - G. M. Teletaeva
- Menampilkan 1 - 11 hasil dari 11
-
1
-
2
-
3
PERORAL FORMS OF CYTOSTATIC DRUGS IN THERAPY OF METASTATIC MAMMARY GLAND CANCER: ROLE IN CLINICAL PRACTICE oleh G. M. TELETAEVA, T. Y. SEMIGLAZOVA, А. S. ZHABINA, D. H. LATIPOVA, V. V. KLIMENKO, Z. S. KOTOVA, A. I. SEMENOVA, S. A. PROTSENKO, V. V. SEMIGLAZOV
Diterbitkan 2016-12-01
Artikel -
4
-
5
TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS oleh T. Y. SEMIGLAZOVA, A. S. ZHABINA, А. V. BELYAEVA, V. A. KLUGE, K. V. USOVA, D. H. LATIPOVA, G. M. TELETAEVA, A. V. NOVIK, A. I. SEMENOVA, S. A. PROTSENKO
Diterbitkan 2016-12-01
Artikel -
6
Successful treatment of high-risk gestational trophoblastic disease in a patient with intolerance to standard chemotherapy (clinical case) oleh G. M. Teletaeva, E. A. Ulrikh, D. Kh. Latipova, A. I. Semenova, E. V. Levchenko, D. G. Ulrikh, I. V. Berlev, T. Yu. Semiglazova, S. A. Protsenko, A. F. Urmancheeva
Diterbitkan 2021-01-01
Artikel -
7
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer oleh T Yu Semiglazova, V A Klyuge, V V Semiglazov, G M Teletaeva, P V Krivorotko, G A Dashyan, R M Paltuev, E V Tkachenko, R V Donskikh, V F Semiglazov
Diterbitkan 2016-06-01
Artikel -
8
Trophoblastic neoplasia on the background of developing pregnancy: a rare gynecological tumor with a chance of favorable outcome for mother and fetus oleh E. A. Ulrikh, E. L. Dikareva, A. D. Dzharbaeva, O. A. Zhamborova, T. M. Pervuninа, E. V. Komlichenko, S. A. Protsenko, G. M. Teletaeva, O. A. Li, A. S. Artemyeva, I. A. Mashenko, G. F. Kutusheva, T. Yu. Semiglazova, А. F. Urmancheeva
Diterbitkan 2022-12-01
Artikel -
9
NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES oleh T. Y. SEMIGLAZOVA, V. A. KLYUGE, E. A. KOROBEYNIKOVA, P. V. KRIVOROTKO, R. M. PALTUEV, G. M. TELETAEVA, D. H. LATIPOVA, V. V. KLIMENKO, E. V. TACHENKO, A. V. Novik, A. I. SEMENOVA, V. V. SEMIGLAZOV, S. A. PROTSENKO, V. F. SEMIGLAZOV
Diterbitkan 2017-06-01
Artikel -
10
Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia oleh N. S. Besova, T. A. Titova, E. V. Artamonova, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukal’chuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, A. A. Tryakin, I. S. Stilidi
Diterbitkan 2019-12-01
Artikel -
11
Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA t... oleh N. S. Besova, T. A. Titova, Е. V. Artamonova, A. A. Tryakin, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukalchuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, I. S. Stilidi
Diterbitkan 2020-07-01
Artikel